Fosså A, Smeland K, Fagerli UM, Galleberg RB, Bersvendsen HS, Holte H (2019)
Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016
Acta Oncol, 1-5 (in press)
DOI 10.1080/0284186X.2019.1652765, PubMed 31429371

Lockmer S, Ren W, Brodtkorb M, Østenstad B, Wahlin BE, Pan-Hammarström Q, Kimby E (2019)
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy
Br J Haematol (in press)
DOI 10.1111/bjh.16159, PubMed 31423576

Lindholm EM, Ragle Aure M, Haugen MH, Sahlberg KK, Kristensen VN, Nebdal D, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2019)
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
Mol Oncol (in press)
DOI 10.1002/1878-0261.12561, PubMed 31402562